FEATURED

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

  • All
  • Education
  • Events
  • Press Releases
See more news
See more press releases

Social media

nspharmainc NS Pharma @nspharmainc ·
1 Apr

Please welcome Alfred Freeman to NS Pharma’s Clinical Research team!

With 10+ years in clinical trial management, regulatory compliance and process optimization, Alfred brings experience from Neumora, Regeneron and more. We’re excited to have you on the team!

#NewHire #NSPharma https://x.com/NSPharmaInc/status/2039342709861654650/photo/1

nspharmainc NS Pharma @nspharmainc ·
31 Mar

The dystrophin gene has 79 exons. #ExonSkipping therapies aim to skip specific exons to help the body work around certain mutations.

Genetic testing can identify which exons are affected and if this approach may apply.

Learn more: https://ow.ly/b9Ux50YB63L

#Duchenne #NSPharma https://x.com/NSPharmaInc/status/2038916684778545393/photo/1

nspharmainc NS Pharma @nspharmainc ·
27 Mar

We’re looking forward to this upcoming community event and the chance to engage in meaningful conversations around #RareDisease care.

Listening, learning and sharing perspectives helps move progress forward. We look forward to connecting!

Learn more: https://ow.ly/kJST50YzCCz https://x.com/NSPharmaInc/status/2037545713618300979/photo/1

nspharmainc NS Pharma @nspharmainc ·
25 Mar

When the immune system turns against the body, rare diseases like #EGPA can emerge.

Marked by asthma, rashes, and nerve pain, EGPA involves overactive eosinophils and inflammation.

NS-229, a JAK1 inhibitor, is now in a global Phase 2 trial.

Learn More: https://ow.ly/AUPf50YyAY3 https://x.com/NSPharmaInc/status/2036820476673052777/video/1

nspharmainc NS Pharma @nspharmainc ·
24 Mar

Duchenne is part of the story, not the whole story.

Brantley was diagnosed with DMD at 4. #ExonSkipping therapies can help produce a usable form of dystrophin, slowing progression so patients can keep pursuing what they love.

Learn more: https://ow.ly/tLgj50Yy39p https://x.com/NSPharmaInc/status/2036458150723768404/video/1

nspharmainc NS Pharma @nspharmainc ·
20 Mar

We’re proud to support the 2026 Brian McKenna #TetraSki Express National Championship on March 27 in Utah!

This inspiring event showcases adaptive technology, resilience and athleticism in downhill racing.

Learn more: http://www.tetraski.us/tetraski-express

#AdaptiveSports #NSPharma https://x.com/NSPharmaInc/status/2034993922947063856/photo/1

nspharmainc NS Pharma @nspharmainc ·
18 Mar

We’re glad to be part of this upcoming #CureDuchenne event!

These moments help us reflect, connect and stay focused on improving care and access. We look forward to seeing you there.

Learn more: https://web.cvent.com/event/a4ee9964-3748-4016-b032-1b4c3b2df2f0/summary

#NSPharma https://x.com/NSPharmaInc/status/2034284219602489364/photo/1